[
    [
        {
            "time": "",
            "original_text": "通策医疗受监管关注，解决潜在同业竞争的承诺延期且未及时披露，其他违规处罚",
            "features": {
                "keywords": [
                    "通策医疗",
                    "监管关注",
                    "同业竞争",
                    "承诺延期",
                    "信息披露",
                    "违规处罚"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "通策医疗受监管关注，解决潜在同业竞争的承诺延期且未及时披露，其他违规处罚",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "中国银河-通策医疗：疫情影响消散，通策模式快速发展【公司研究】",
            "features": {
                "keywords": [
                    "中国银河",
                    "通策医疗",
                    "疫情影响",
                    "通策模式",
                    "快速发展",
                    "公司研究"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "中国银河-通策医疗：疫情影响消散，通策模式快速发展【公司研究】",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "通策医疗及股东信披违规，董事长吕建明等遭监管关注，其他违规处罚",
            "features": {
                "keywords": [
                    "通策医疗",
                    "信披违规",
                    "董事长",
                    "吕建明",
                    "监管关注",
                    "违规处罚"
                ],
                "sentiment_score": -0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "通策医疗及股东信披违规，董事长吕建明等遭监管关注，其他违规处罚",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]